SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 40 filers reported holding SOLENO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,165,000 | -20.2% | 18,022,602 | 0.0% | 1.01% | -10.0% |
| Q1 2022 | $3,965,000 | -6.1% | 18,022,602 | +74.9% | 1.12% | +9.9% |
| Q4 2021 | $4,224,000 | -55.5% | 10,302,602 | 0.0% | 1.02% | -52.5% |
| Q3 2021 | $9,500,000 | -18.4% | 10,302,602 | 0.0% | 2.16% | -40.1% |
| Q2 2021 | $11,642,000 | -10.3% | 10,302,602 | 0.0% | 3.60% | -19.7% |
| Q1 2021 | $12,981,000 | -34.7% | 10,302,602 | 0.0% | 4.48% | -34.1% |
| Q4 2020 | $19,884,000 | -22.8% | 10,302,602 | 0.0% | 6.80% | +23.5% |
| Q3 2020 | $25,757,000 | +13.1% | 10,302,602 | 0.0% | 5.51% | -13.5% |
| Q2 2020 | $22,769,000 | +45.2% | 10,302,602 | +47.8% | 6.37% | -38.9% |
| Q1 2020 | $15,681,000 | -21.3% | 6,969,272 | 0.0% | 10.41% | +8.1% |
| Q4 2019 | $19,932,000 | +188.4% | 6,969,272 | +49.3% | 9.63% | +120.4% |
| Q3 2019 | $6,911,000 | -43.1% | 4,669,272 | 0.0% | 4.37% | -6.1% |
| Q2 2019 | $12,140,000 | +26.2% | 4,669,272 | 0.0% | 4.66% | -45.9% |
| Q1 2019 | $9,619,000 | +20.5% | 4,669,272 | 0.0% | 8.61% | +18.7% |
| Q4 2018 | $7,984,000 | – | 4,669,272 | – | 7.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|